Amgen Inc. (AMGN)

225.09
0.28 0.12
NASDAQ : Health Technology
Prev Close 224.81
Day Low/High 222.25 / 226.62
52 Wk Low/High 166.68 / 244.99
Avg Volume 3.44M
Exchange NASDAQ
Shares Outstanding 588.25M
Market Cap 130.83B
EPS 13.00
P/E Ratio 17.60
Div & Yield 6.40 (2.68%)
This 2019 Market Optimism Is Misplaced: Market Recon

This 2019 Market Optimism Is Misplaced: Market Recon

Take upbeat outlooks for equities with a grain of salt, and try these sectors to stay safe.

The Real Money Post-Industrial Average Has Jumped 11% So Far This Year

The Real Money Post-Industrial Average Has Jumped 11% So Far This Year

For the month of November RMPIA climbed 1.2% month over month.

Pfizer Shares Jump on Monday After Company Signals Higher Price Push

Pfizer Shares Jump on Monday After Company Signals Higher Price Push

Pfizer pushes higher on price increases.

Tech Selloff Could Work in Favor of Pharmaceutical Stocks

Tech Selloff Could Work in Favor of Pharmaceutical Stocks

Pharma could be the best parking spot for your money if the market keeps trending downward.

Amgen Is Showing Independent Strength in a Bullish Sign for the Future

Amgen Is Showing Independent Strength in a Bullish Sign for the Future

Investors should continue to hold Amgen.

Jim Cramer: Even Safe-Haven Big-Cap Drug Stocks Are Now Broken

Jim Cramer: Even Safe-Haven Big-Cap Drug Stocks Are Now Broken

Once the safest stocks in the book, the big-cap drug companies are now toxic.

Staying Long Apple Into Tuesday's Product Launch: Market Recon

Staying Long Apple Into Tuesday's Product Launch: Market Recon

My target price and panic points have changed, and I am watching for a chance to add or shave some off, depending on which direction the stock takes.

Here Are 9 Takeaways From Last Night's Meltdown: Market Recon

Here Are 9 Takeaways From Last Night's Meltdown: Market Recon

It becomes difficult for me to tell you where to run in these markets...

Jim Cramer: These Are the Stocks to Buy on Canada Deal and the 4th Quarter

Jim Cramer: These Are the Stocks to Buy on Canada Deal and the 4th Quarter

Straying from these names could land you in quicksand as the 4th quarter begins.

Novice Trade: Amgen

Novice Trade: Amgen

Amgen calls just look too cheap to pass up here.

Jim Cramer: 5 Sectors to Buy on This 'Turkish Contagion' Market Drop

Jim Cramer: 5 Sectors to Buy on This 'Turkish Contagion' Market Drop

It is all about perception, and here are strong names to pick up on market weakness.

Biotechs: Adding to Radius Health, Flexion

Biotechs: Adding to Radius Health, Flexion

This downward action in the small biotech sector tends to happen often in the 'dog days' of summer.

3 Best Ways to Play Amazon, Starbucks and Amgen After Earnings

3 Best Ways to Play Amazon, Starbucks and Amgen After Earnings

Here are 3 ways to play these 3 stocks on earnings.

Charting 3 Big Names After Earnings

Charting 3 Big Names After Earnings

How to play Amazon, Starbucks and Amgen on earnings news.

Biotech Stocks Rally on Biogen's Landmark Test

Biotech Stocks Rally on Biogen's Landmark Test

Investors might be finally recognizing the hidden value of the firms' drug research and development.

Amgen Is Ready to Breakout on the Upside

Amgen Is Ready to Breakout on the Upside

Let's go to the charts.

Jim Cramer: Move Over FANG, Long Live INJFANG

Jim Cramer: Move Over FANG, Long Live INJFANG

The Nasdaq hit an all-time high today, and It's Not Just FANG anymore.

Emboldened By Biotech Names

Emboldened By Biotech Names

For the trade, I'm opting to use the iShares Nasdaq Biotechnology ETF.

When the Stock Is the Only Option

When the Stock Is the Only Option

Options spreads aren't tradable with some small biotechs, making shares the only way to play.

Jim Cramer: Are Markets Getting Tired of Trump, Trade and Tariffs?

Jim Cramer: Are Markets Getting Tired of Trump, Trade and Tariffs?

Sooner or later, bargain hunters will say: 'Enough already. It can't be that bad.'

Feels Like the Semis Are Skating on Thin Ice: Market Recon

Feels Like the Semis Are Skating on Thin Ice: Market Recon

Forward looking valuations, except for Nvidia, are very low.

Here's My Take on Biotech Stocks

Here's My Take on Biotech Stocks

I think M&A activity will pick up markedly going forward across the industry.

These 2 Widely Held Stocks Look Good Short

These 2 Widely Held Stocks Look Good Short

Our 'bearish bets' show weak technical characteristics and have received recent quant downgrades.

Cramer vs. Chaikin: Amgen -- Be Careful of This Stock

Cramer vs. Chaikin: Amgen -- Be Careful of This Stock

TheStreet's Jim Cramer and Marc Chaikin, of Chaikin Analytics, spent an hour together at our offices talking all things markets. Listen to the whole conversation below. In the except above, they discuss Amgen and why Chaikin says to be careful of the stock.

The Shifting Price Action Continued Today

The Shifting Price Action Continued Today

The good news is that volatility is increasing. The bad news, for some, is that it moves in both directions.

The Really Big Money Rushes to Super Bowl

The Really Big Money Rushes to Super Bowl

This will be the ninth consecutive year when the big game tops that 100 million-viewers mark.

Cramer: Step Away and Get Your Clients Better Prices

Cramer: Step Away and Get Your Clients Better Prices

You mean to tell me if the buyers walked away for 10 minutes they couldn't get these stocks lower?

Jim Cramer: Stocks Are on Fire For Good Reasons

Jim Cramer: Stocks Are on Fire For Good Reasons

Stocks put in broad gains supported by tax cuts, bonuses, a weaker dollar and more.

3 More Stocks To Buy on Tax Reform

3 More Stocks To Buy on Tax Reform

Rent-A-Center, Foot Locker and AV Homes will get a nice holiday gift with the tax deal.

7 Hot Investing Bets to Make in Biotech

7 Hot Investing Bets to Make in Biotech

These favorite names in the volatile sector offer the potential for high rewards.